Post by Pangea Laboratory

June is Men’s Health Month, a time for raising awareness of preventable conditions and encouraging men to take early action. Bladder cancer belongs in that conversation. It’s the 4th most common cancer in men, and men are 3–4 times more likely to be diagnosed than women. Yet the signs are routinely dismissed by patients. Often painless: blood in the urine without discomfort is a recognized early sign. Other signs, like frequent urination or burning when urinating, are often mistaken for a bladder infection. This Men’s Health Month, our message is simple: don’t ignore what your body may be telling you. Early detection of bladder cancer is often associated with less intensive treatment and better outcomes, with survival rates reaching up to 90% depending on stage at diagnosis.† When it’s time for testing, Bladder CARE™ provides clinically validated information from urine that may help guide further evaluation. Bladder CARE™ is a laboratory-developed test that detects bladder cancer from a urine sample collected at home and analyzed in a certified laboratory.* Early action might make a difference in outcomes. *The Bladder CARE™ home kit is used only for urine sample collection. Sample analysis is performed by a clinical laboratory as part of a laboratory-developed test. †HealthGrades. Carcinoma in Situ: What to Know About Stage 0 Cancer. #PangeaLaboratory #MedicalLaboratory #MensHealthMonth

Video Content